New Study in JNCCN Supports Chemotherapy Option That Reduces Side Effects for People with Gastrointestinal Cancers

New research just-published online by JNCCN—Journal of the National Comprehensive Cancer Network finds that for many commonly used treatment regimens targeting metastatic GI cancers, it is possible to administer 5-FU solely through continuous infusion, minus the bolus component, without negatively affecting patient outcomes.